Profile
Brandy Wilkinson worked as Vice President-Operations & Research at Explora BioLabs, Inc. from 2020 to 2022.
Former positions of Brandy Wilkinson
| Companies | Position | End |
|---|---|---|
Explora BioLabs, Inc.
 Explora BioLabs, Inc. BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., Explora BioLabs, Inc. is a company that provides vivarium and contract research services to biotechnology organizations. The company, based in San Diego, CA, offers on- and off-site vivarium services, including vivarium management, facility design, rodent housing and equipment, supply chain management, regulatory oversight, and veterinary/husbandry staffing. Explora BioLabs has a team of Ph.D.-level scientists with experience in the preclinical in vivo workflow, and their suite of vivarium-as-a-service solutions allows biotech companies to begin in vivo studies quickly. The company was founded by Richard Lin. Explora BioLabs was acquired by Charles River Laboratories International, Inc. on April 06, 2022 for $295 million. | Chief Operating Officer | 2022-05-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Explora BioLabs, Inc.
Explora BioLabs, Inc. BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., Explora BioLabs, Inc. is a company that provides vivarium and contract research services to biotechnology organizations. The company, based in San Diego, CA, offers on- and off-site vivarium services, including vivarium management, facility design, rodent housing and equipment, supply chain management, regulatory oversight, and veterinary/husbandry staffing. Explora BioLabs has a team of Ph.D.-level scientists with experience in the preclinical in vivo workflow, and their suite of vivarium-as-a-service solutions allows biotech companies to begin in vivo studies quickly. The company was founded by Richard Lin. Explora BioLabs was acquired by Charles River Laboratories International, Inc. on April 06, 2022 for $295 million. | Health Technology |
- Stock Market
- Insiders
- Brandy Wilkinson
